What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Gene
His primary areas of investigation include Internal medicine, Endocrinology, Bone remodeling, Osteoporosis and Bone disease.
His Internal medicine research integrates issues from Peripheral blood mononuclear cell and Cell nucleus.
His work deals with themes such as Osteocalcin, Mesenchymal stem cell and Osteoblast, which intersect with Endocrinology.
Erik Fink Eriksen combines subjects such as Calcium, Osteoclast, Osteoid, Iliac crest and Biopsy with his study of Bone remodeling.
Erik Fink Eriksen interconnects Surgery and Urology in the investigation of issues within Osteoporosis.
His Bone disease research is multidisciplinary, relying on both Risedronic acid, Vitamin and vitamin D deficiency.
His most cited work include:
- Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. (3630 citations)
- Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis: A Randomized Controlled Trial (2169 citations)
- Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis (2156 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Osteoporosis, Bone remodeling and Bone mineral.
Erik Fink Eriksen combines topics linked to Gastroenterology with his work on Internal medicine.
His studies deal with areas such as Osteocalcin, N-terminal telopeptide, Calcium and Osteoblast as well as Endocrinology.
The Osteoporosis study combines topics in areas such as Urology and Surgery, Zoledronic acid.
He focuses mostly in the field of Bone remodeling, narrowing it down to topics relating to Bone cell and, in certain cases, Bone remodeling period.
The concepts of his Bone mineral study are interwoven with issues in Body mass index, Dentistry and Femoral neck.
He most often published in these fields:
- Internal medicine (69.14%)
- Endocrinology (49.71%)
- Osteoporosis (40.29%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (69.14%)
- Osteoporosis (40.29%)
- Bone remodeling (37.14%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Osteoporosis, Bone remodeling, Bone mineral and Endocrinology are his primary areas of study.
Internal medicine is closely attributed to Gastroenterology in his study.
His study in Osteoporosis is interdisciplinary in nature, drawing from both Physical therapy and Randomized controlled trial, Surgery.
His research integrates issues of Osteoarthritis, Angiogenesis, Cortical bone, Prospective cohort study and N-terminal telopeptide in his study of Bone remodeling.
His Bone mineral research incorporates themes from Body mass index, Dentistry and Femoral neck.
As part of the same scientific family, Erik Fink Eriksen usually focuses on Endocrinology, concentrating on Pyridinoline and intersecting with Matrix and Iliac crest.
Between 2015 and 2021, his most popular works were:
- Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS. (194 citations)
- Epidemiology and health related quality of life in hypoparathyroidism in Norway (105 citations)
- Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS and SIOG. (93 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Gene
Erik Fink Eriksen mainly focuses on Internal medicine, Bone remodeling, Endocrinology, Bone mineral and Osteoporosis.
His Internal medicine study integrates concerns from other disciplines, such as Ocular complication and Lacrimal gland.
His work carried out in the field of Bone remodeling brings together such families of science as Cortical bone, Bone Density Conservation Agents, Denosumab, Bone marrow and N-terminal telopeptide.
His Endocrinology research is multidisciplinary, incorporating perspectives in Eye disease and Lacritin.
His work in the fields of Teriparatide overlaps with other areas such as Bone material.
His work on Oral bisphosphonates as part of general Osteoporosis study is frequently connected to Institutional repository, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
